
Tuberculosis surveillance in Europe 2007: surveillance report / European Centre for Disease Prevention and Control;World Health Organization. Regional Office for Europe
Tác giả : European Centre for Disease Prevention and Control;World Health Organization. Regional Office for Europe
Nhà xuất bản : European Centre for Disease Prevention and Control & World Health Organization. Regional Office for Europe
Năm xuất bản : 2009
ISBN : 9789289060653 (PDF)
Chủ đề : 1. Data Collection. 2. Epidemiological Monitoring -- statistics and numerical data. 3. Europe. 4. Public Health Surveillance -- prevention and control. 5. Tuberculosis -- epidemiology. 6. Publications.
Thông tin chi tiết
Tóm tắt : | Since 1st January 2008, the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe have jointly been coordinating the tuberculosis (TB) surveillance in Europe. Their aim is to ensure a high quality of TB standardized data covering all 53 countries in the WHO European Region. In 2007, 477 327 cases of TB were reported by the 51 countries of the WHO European Region plus Liechtenstein. The overall notification rate averaged 54 cases per 100 000, with a wide variability between countries and an incremental west-to-east gradient evident in recent years. This represents an increase of 54 497 cases from 2006 and an overall notification rate increase of 13% (from 48/100 000 to 54/100 000), mainly attributable to the registration by the Russian Federation of previously unreported re-treated cases, following the expansion of its notification system coverage and improved patient access to care. The notification rate of previously untreated cases in the entire Region decreased by 2.5% (from 36.6 to 35.7 per 100 000). In general, TB mortality rates in recent years mirrored overall notification rates in their geographical distribution across the Region (median overall rate: 0.6/100 000, country range: 0.0–22.3). The median level of primary multidrug-resistant TB (MDR-TB) was 1.5% in the 22 countries reporting MDR-TB data. The average treatment success rate was 73%, with 11% of cases lost to follow-up, 8% death and 7% failures of treatment. v, 133 p. |
Thông tin dữ liệu nguồn
Thư viện | Ký hiệu xếp giá | Dữ liệu nguồn |
---|---|---|
![]() |
|
https://iris.who.int/handle/10665/374524 |